GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » BioNeutra Global Corp (TSXV:BGA) » Definitions » Long-Term Capital Lease Obligation

BioNeutra Global (TSXV:BGA) Long-Term Capital Lease Obligation : C$0.00 Mil (As of Mar. 2024)


View and export this data going back to 1999. Start your Free Trial

What is BioNeutra Global Long-Term Capital Lease Obligation?

BioNeutra Global's Long-Term Capital Lease Obligation for the quarter that ended in Mar. 2024 was C$0.00 Mil.

BioNeutra Global's quarterly Long-Term Capital Lease Obligation declined from Sep. 2023 (C$0.04 Mil) to Dec. 2023 (C$0.02 Mil) and declined from Dec. 2023 (C$0.02 Mil) to Mar. 2024 (C$0.00 Mil).

BioNeutra Global's annual Long-Term Capital Lease Obligation increased from Dec. 2021 (C$0.00 Mil) to Dec. 2022 (C$0.10 Mil) but then declined from Dec. 2022 (C$0.10 Mil) to Dec. 2023 (C$0.02 Mil).


BioNeutra Global Long-Term Capital Lease Obligation Historical Data

The historical data trend for BioNeutra Global's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioNeutra Global Long-Term Capital Lease Obligation Chart

BioNeutra Global Annual Data
Trend Feb14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Long-Term Capital Lease Obligation
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 0.10 0.02

BioNeutra Global Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Long-Term Capital Lease Obligation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.08 0.08 0.04 0.02 -

BioNeutra Global  (TSXV:BGA) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

BioNeutra Global Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of BioNeutra Global's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.


BioNeutra Global (TSXV:BGA) Business Description

Traded in Other Exchanges
Address
9608 - 25 Avenue NW, Edmonton, AB, CAN, T6N 1J4
BioNeutra Global Corp is engaged in the research, development, production, and commercialization of food ingredients for neutraceutical, functional and mainstream foods, focusing on oligosaccharides. Its product portfolio provides ingredients for various food systems, that contribute to human nutrition and wellness in functional and healthy foods. Its prime product, VitaFiber IMO, is offered in both powder and syrup form. The company operates in Canada while generating sales revenue from various countries internationally. It has a single industry segment, manufacturing and trading of products. The majority of the revenue is derived from the United States.
Executives
Monica Barclay Senior Officer

BioNeutra Global (TSXV:BGA) Headlines

No Headlines